CELLCENTRIC LTD
8Patents
8Active
8Granted
46Portfolio score
Filing activity: Apr 10, 2007 → May 14, 2020 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8658393B2 | Molecules and methods for demethylation of methylated nucleic acid sequences | Chemistry; Metallurgy | 5 | Active |
| US10118920B2 | Isoxazolyl substituted benzimidazoles | Chemistry; Metallurgy | 2 | Active |
| US10647704B2 | Pharmaceutical compounds | Human Necessities | 0 | Active |
| US10696666B2 | Pharmaceutical compounds | Human Necessities | 0 | Active |
| US11377443B2 | Pharmaceutical compounds | Human Necessities | 0 | Active |
| US8298529B2 | Compositions and method for epigenetic modification of nucleic acid sequences in vivo | Chemistry; Metallurgy | 0 | Active |
| US10428065B2 | Isoxazolyl substituted imidazopyridines | Human Necessities | 0 | Active |
| US11453662B2 | Process for preparing modulators of p300 and/or CBP | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.